ReviewCurrent atherosclerosis reports2025
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
Marta Biolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCurrent atherosclerosis reports2025
Marta Biolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.